Business Description
Valiant Laboratories Ltd
ISIN : INE0JWS01017
Total Employee Number:
79Compare
Compare
Traded in other countries / regions
543998.India IPO Date
2023-10-06Description
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.72 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | 5.3 | |||||
Interest Coverage | 0.19 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.23 | |||||
Beneish M-Score | -2.09 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.6 | |||||
3-Year EBITDA Growth Rate | -45.8 | |||||
3-Year Book Growth Rate | 38.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.15 | |||||
9-Day RSI | 39.79 | |||||
14-Day RSI | 41.1 | |||||
3-1 Month Momentum % | 37.08 | |||||
6-1 Month Momentum % | 3.89 | |||||
12-1 Month Momentum % | -27.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.91 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 47.17 | |||||
Days Sales Outstanding | 113.52 | |||||
Days Payable | 113.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.1 | |||||
Shareholder Yield % | 15.97 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.98 | |||||
Operating Margin % | 0.15 | |||||
Net Margin % | -1.38 | |||||
EBITDA Margin % | 3.67 | |||||
FCF Margin % | -18.8 | |||||
OCF Margin % | -4.39 | |||||
ROE % | -1.14 | |||||
ROA % | -0.76 | |||||
ROC (Joel Greenblatt) % | 0.89 | |||||
ROCE % | 0.77 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.46 | |||||
PB Ratio | 1.16 | |||||
Price-to-Tangible-Book | 1.16 | |||||
EV-to-EBIT | 139.7 | |||||
EV-to-EBITDA | 42.98 | |||||
EV-to-Revenue | 1.58 | |||||
EV-to-FCF | -8.4 | |||||
Price-to-GF-Value | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 4.81 | |||||
Earnings Yield (Greenblatt) % | 0.72 | |||||
FCF Yield % | -12.33 | |||||
Forward Rate of Return (Yacktman) % | -61.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valiant Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 2,374.674 | ||
| EPS (TTM) (₹) | -0.69 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 63.43 | ||
| 14-Day RSI | 41.1 | ||
| 14-Day ATR (₹) | 3.219335 | ||
| 20-Day SMA (₹) | 70.7705 | ||
| 12-1 Month Momentum % | -27.9 | ||
| 52-Week Range (₹) | 49.51 - 115.054214 | ||
| Shares Outstanding (Mil) | 54.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valiant Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valiant Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Valiant Laboratories Ltd Frequently Asked Questions
What is Valiant Laboratories Ltd(NSE:VALIANTLAB)'s stock price today?
The current price of NSE:VALIANTLAB is ₹68.00. The 52 week high of NSE:VALIANTLAB is ₹115.05 and 52 week low is ₹49.51.
When is next earnings date of Valiant Laboratories Ltd(NSE:VALIANTLAB)?
The next earnings date of Valiant Laboratories Ltd(NSE:VALIANTLAB) is .
Does Valiant Laboratories Ltd(NSE:VALIANTLAB) pay dividends? If so, how much?
Valiant Laboratories Ltd(NSE:VALIANTLAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Valiant Laboratories Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers